1) Atrial septal defect (ASD) accounts for 10-30% of congenital heart defects. Surgical closure has traditionally been the standard treatment but is associated with risks.
2) Device closure of ASD is now preferred due to lower risks compared to surgery. It avoids complications of surgery and cardiopulmonary bypass while allowing shorter recovery.
3) The document describes the steps of ASD device closure including imaging and sizing the defect, choosing an appropriately sized device, and techniques for more difficult cases with inadequate rims. Device closure is now established as the treatment of choice for most ASD patients.